PL370559A1 - Monohydrat chlorowodorku wenlafaksyny i sposoby jego wytwarzania - Google Patents

Monohydrat chlorowodorku wenlafaksyny i sposoby jego wytwarzania

Info

Publication number: PL370559A1
Authority: PL; Poland
Prior art keywords: preparation; methods; hydrochloride monohydrate; venlafaxine hydrochloride; venlafaxine
Prior art date: 2001-12-05

Application number

PL02370559A

Other languages

English (en)

Inventor

Jun Han

Yong Jai Lee

Original Assignee

Wyeth

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-12-05

Filing date

2002-12-03

Publication date

2005-05-30

2002-12-03 Application filed by Wyeth filed Critical Wyeth

2005-05-30 Publication of PL370559A1 publication Critical patent/PL370559A1/pl

Links

229960002416 venlafaxine hydrochloride Drugs 0.000 title 1
QYRYFNHXARDNFZ-UHFFFAOYSA-N venlafaxine hydrochloride Chemical compound [H+].[Cl-].C1=CC(OC)=CC=C1C(CN(C)C)C1(O)CCCCC1 QYRYFNHXARDNFZ-UHFFFAOYSA-N 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C217/74—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
General Chemical & Material Sciences (AREA)
Neurology (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Neurosurgery (AREA)
Emergency Medicine (AREA)
Epidemiology (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

PL02370559A 2001-12-05 2002-12-03 Monohydrat chlorowodorku wenlafaksyny i sposoby jego wytwarzania PL370559A1 (pl)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US33582301P	2001-12-05	2001-12-05

Publications (1)

Publication Number	Publication Date
PL370559A1 true PL370559A1 (pl)	2005-05-30

Family

ID=23313363

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL02370559A PL370559A1 (pl)	2001-12-05	2002-12-03	Monohydrat chlorowodorku wenlafaksyny i sposoby jego wytwarzania

Country Status (20)

Country	Link
US (2)	US20030114536A1 (pl)
EP (1)	EP1451146A1 (pl)
JP (1)	JP2005511737A (pl)
KR (1)	KR20050044711A (pl)
CN (1)	CN1599715A (pl)
AR (1)	AR037636A1 (pl)
AU (1)	AU2002366574A1 (pl)
BR (1)	BR0214696A (pl)
CA (1)	CA2467614A1 (pl)
CO (1)	CO5580817A2 (pl)
EC (1)	ECSP045134A (pl)
HU (1)	HUP0402553A2 (pl)
MX (1)	MXPA04005307A (pl)
NO (1)	NO20042810L (pl)
PL (1)	PL370559A1 (pl)
RU (1)	RU2004120273A (pl)
TW (1)	TW200300669A (pl)
UA (1)	UA77234C2 (pl)
WO (1)	WO2003050076A1 (pl)
ZA (1)	ZA200405245B (pl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MXPA04005305A (es) *	2001-12-05	2004-09-13	Wyeth Corp	Nuevo polimorfo cristalino de clorhidrato de venlafaxina y metodos para preparacion del mismo.
KR20070034129A (ko) *	2004-07-22	2007-03-27	와이어쓰	신경계 질환 및 장애의 치료 방법
EP1773321A2 (en) *	2004-07-22	2007-04-18	Wyeth	Method for treating nervous system disorders and conditions
RU2007102292A (ru) *	2004-07-22	2008-08-27	Вайет (Us)	Способ лечения расстройств и заболеваний нервной системы
WO2007047972A2 (en) *	2005-10-19	2007-04-26	Teva Pharmaceutical Industries Ltd.	Process for the preparation of highly pure 1-[2-dimethylamino-(4-methoxyphenyl) ethyl]cyclohexanol hydrochloride
EP2436381A1 (en)	2006-06-27	2012-04-04	Sandoz AG	Crystallization of hydrohalides of pharmaceutical compounds
DK2792662T3 (da)	2007-05-01	2016-07-25	Concert Pharmaceuticals Inc	Morphinanforbindelser
US20120083487A1 (en) *	2008-10-30	2012-04-05	Amanda Thomas	Combination of morphinan compounds and antidepressant for the treatment of pseudobulbar affect, neurolgical diseases, intractable and chronic pain and brain injury
WO2017040611A1 (en) *	2015-08-31	2017-03-09	Nutramax Laboratories, Inc.	Compositions comprising magnolia, phellodendron, theanine and/or whey protein

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK0639374T3 (da) *	1993-06-28	2002-05-06	American Home Prod	Nye behandlingsmetoder ved anvendelse af phenethylderivater
TW344661B (en) *	1993-11-24	1998-11-11	Lilly Co Eli	Pharmaceutical composition for treatment of incontinence
US5530013A (en) *	1994-02-14	1996-06-25	American Home Products Corporation	Venlafaxine in the inducement of cognition enhancement
US5506270A (en) *	1995-01-30	1996-04-09	American Home Products Corporation	Venlafaxine in the treatment of hypothalamic amenorrhea in non-depressed women
US6274171B1 (en) *	1996-03-25	2001-08-14	American Home Products Corporation	Extended release formulation of venlafaxine hydrochloride
AU2002241764A1 (en) *	2000-10-19	2002-06-18	Teva Pharmaceutical Industries Ltd.	Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof
US20020183553A1 (en) *	2000-10-19	2002-12-05	Ben-Zion Dolitzky	Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof
CA2426393C (en) *	2000-10-31	2012-05-29	Ciba Specialty Chemicals Holding Inc.	Crystalline forms of venlafaxine hydrochloride
WO2002046140A1 (en) *	2000-12-07	2002-06-13	Dr. Reddy's Laboratories Ltd.	Novel crystalline polymorphic forms of venlafaxine hydrochloride and a process for their preparation

2002
- 2002-03-12 UA UA20040705309A patent/UA77234C2/uk unknown
- 2002-12-03 CA CA002467614A patent/CA2467614A1/en not_active Abandoned
- 2002-12-03 KR KR1020047008653A patent/KR20050044711A/ko not_active Withdrawn
- 2002-12-03 AU AU2002366574A patent/AU2002366574A1/en not_active Abandoned
- 2002-12-03 MX MXPA04005307A patent/MXPA04005307A/es unknown
- 2002-12-03 EP EP02791360A patent/EP1451146A1/en not_active Withdrawn
- 2002-12-03 BR BR0214696-7A patent/BR0214696A/pt not_active IP Right Cessation
- 2002-12-03 RU RU2004120273/04A patent/RU2004120273A/ru not_active Application Discontinuation
- 2002-12-03 CN CNA028242394A patent/CN1599715A/zh active Pending
- 2002-12-03 JP JP2003551103A patent/JP2005511737A/ja not_active Withdrawn
- 2002-12-03 WO PCT/US2002/038581 patent/WO2003050076A1/en not_active Ceased
- 2002-12-03 US US10/308,472 patent/US20030114536A1/en not_active Abandoned
- 2002-12-03 PL PL02370559A patent/PL370559A1/pl not_active Application Discontinuation
- 2002-12-03 HU HU0402553A patent/HUP0402553A2/hu unknown
- 2002-12-03 TW TW091135029A patent/TW200300669A/zh unknown
- 2002-12-04 AR ARP020104687A patent/AR037636A1/es not_active Application Discontinuation
2004
- 2004-06-01 CO CO04050940A patent/CO5580817A2/es not_active Application Discontinuation
- 2004-06-04 EC EC2004005134A patent/ECSP045134A/es unknown
- 2004-07-01 ZA ZA200405245A patent/ZA200405245B/xx unknown
- 2004-07-02 NO NO20042810A patent/NO20042810L/no not_active Application Discontinuation
2005
- 2005-08-05 US US11/198,041 patent/US20050272822A1/en not_active Abandoned

Also Published As

Publication number	Publication date
TW200300669A (en)	2003-06-16
UA77234C2 (en)	2006-11-15
JP2005511737A (ja)	2005-04-28
AR037636A1 (es)	2004-11-17
NO20042810L (no)	2004-07-02
HUP0402553A2 (hu)	2005-03-29
CN1599715A (zh)	2005-03-23
KR20050044711A (ko)	2005-05-12
ECSP045134A (es)	2004-07-23
MXPA04005307A (es)	2004-09-13
BR0214696A (pt)	2004-11-03
AU2002366574A1 (en)	2003-06-23
RU2004120273A (ru)	2005-03-27
US20050272822A1 (en)	2005-12-08
CO5580817A2 (es)	2005-11-30
CA2467614A1 (en)	2003-06-19
ZA200405245B (en)	2007-01-31
EP1451146A1 (en)	2004-09-01
US20030114536A1 (en)	2003-06-19
WO2003050076A1 (en)	2003-06-19

Legal Events

Date	Code	Title	Description
2010-12-31	REFS	Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)

Publication	Publication Date	Title
IL162253A0 (en)	2005-11-20	Venlafaxine hydrochloride monohydrate and methods for the preparation thereof
EP1423120A4 (en)	2005-12-28	2H-PHTALAZINE-1-ONES AND METHODS OF USE THEREOF
AU2002352978A8 (en)	2003-06-17	Methods and apparatuses for forming microprojection arrays
IL153864A0 (en)	2003-07-31	Cyclic polyamine compounds and methods for the preparation thereof
GB0112699D0 (en)	2001-07-18	Process for the preparation of prostglandins and analogues thereof
EP1434772A4 (en)	2005-05-04	CONNECTIONS AND METHODS
TW589951U (en)	2004-06-01	Fastener
AU2003295841A8 (en)	2004-06-23	High surface area zeolites and methods for preparation and use thereof
IL172666A0 (en)	2006-04-10	Compounds having anti-hcv activity and processes for the preparation thereof
ZA200405245B (en)	2007-01-31	Venlafaxine hydrochloride monohydrate and methods for the preparation thereof
AU2002359694A8 (en)	2003-06-30	Compounds and methods
IL162255A0 (en)	2005-11-20	Novel crystalline polymorph of venlafaxine hydrochloride and methods for the preparation thereof
IL159266A (en)	2010-11-30	Crystalline forms of fexofenadine and processes for the preparation thereof
EP1384598A4 (en)	2007-05-02	MOUNTING BRACKET
AU2003281698A8 (en)	2004-02-16	1-phenylpiperidin-3-one derivatives and processes for the preparation thereof
GB2371273B (en)	2004-01-21	Through anchor and method for manufacturing the same
EP1379240A4 (en)	2009-04-08	CONNECTIONS AND METHODS
AU2002337634A1 (en)	2004-04-30	Process for the preparation of bupropion hydrochloride
IL165030A0 (en)	2005-12-18	Compound and processes for the preparation and usethereof
GB0224011D0 (en)	2002-11-27	Valve device
AU2003244886A1 (en)	2003-09-29	Process for preparing tramadol hydrochloride and/or tramadol momohydrate
TW486048U (en)	2002-05-01	Fastener
HU2206U (en)	2002-01-28	Picture-frame
GB0120236D0 (en)	2001-10-10	Seating device
AU2002338955A1 (en)	2003-04-07	Amines with antialcoholic agents